871 followers
@gcbioinv Less variability in uGAGs has been observed in other contexts eg short-term follow up of ERT for MPS IVA - see Fig 2 https://t.co/V7eYVIUbFB
@gcbioinv Less variability in uGAGs has been observed in other contexts eg short-term follow up of ERT for MPS IVA - see Fig 2 https://t.co/V7eYVIUbFB
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome… https://t.co/Feelpkrj3V